sorafenib has been researched along with oleic acid in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (oleic acid) | Trials (oleic acid) | Recent Studies (post-2010) (oleic acid) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 8,768 | 248 | 3,051 |
Protein | Taxonomy | sorafenib (IC50) | oleic acid (IC50) |
---|---|---|---|
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 6.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, R; Kuang, S; Liu, G; Peng, Q; Sun, C; Wang, J | 1 |
1 other study(ies) available for sorafenib and oleic acid
Article | Year |
---|---|
Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
Topics: Adenosine Triphosphate; Adenylate Kinase; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Enzyme Activation; Fatty Acids, Monounsaturated; Humans; Lipidomics; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Proteins; Oleic Acid; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Sorafenib; Stearoyl-CoA Desaturase; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2019 |